These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29462672)

  • 1. Use of high-dose intermittent systemic glucocorticoids and the risk of fracture in patients with chronic obstructive pulmonary disease.
    Oshagbemi OA; Burden AM; Shudofsky KN; Driessen JHM; Vestergaard P; Krings A; Franssen FME; van den Bergh J; de Vries F
    Bone; 2018 May; 110():238-243. PubMed ID: 29462672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of systemic glucocorticoids and the risk of major osteoporotic fractures in patients with sarcoidosis.
    Oshagbemi OA; Driessen JHM; Pieffers A; Wouters EFM; Geusens P; Vestergaard P; van den Bergh J; Franssen FME; de Vries F
    Osteoporos Int; 2017 Oct; 28(10):2859-2866. PubMed ID: 28638981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of cumulative exposure to high-dose oral glucocorticoids on fracture risk in Denmark: a population-based case-control study.
    Amiche MA; Abtahi S; Driessen JHM; Vestergaard P; de Vries F; Cadarette SM; Burden AM
    Arch Osteoporos; 2018 Mar; 13(1):30. PubMed ID: 29552730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone mineral density and fractures in older men with chronic obstructive pulmonary disease or asthma.
    Dam TT; Harrison S; Fink HA; Ramsdell J; Barrett-Connor E;
    Osteoporos Int; 2010 Aug; 21(8):1341-9. PubMed ID: 19816753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of inhaled glucocorticoids and beta(2) agonists on vertebral fracture risk in COPD patients: the EOLO study.
    Gonnelli S; Caffarelli C; Maggi S; Guglielmi G; Siviero P; Rossi S; Crepaldi G; Nuti R;
    Calcif Tissue Int; 2010 Aug; 87(2):137-43. PubMed ID: 20567964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vertebral fractures in patients with chronic obstructive pulmonary disease: the EOLO Study.
    Nuti R; Siviero P; Maggi S; Guglielmi G; Caffarelli C; Crepaldi G; Gonnelli S
    Osteoporos Int; 2009 Jun; 20(6):989-98. PubMed ID: 18931817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of vertebral and non-vertebral fractures in patients with sarcoidosis: a population-based cohort.
    Bours S; de Vries F; van den Bergh JPW; Lalmohamed A; van Staa TP; Leufkens HGM; Geusens PPP; Drent M; Harvey NC
    Osteoporos Int; 2016 Apr; 27(4):1603-1610. PubMed ID: 26630976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of fractures among patients receiving medications for type 2 diabetes or chronic obstructive pulmonary disease and glucocorticoid users according to the National Claims Database in Japan.
    Fujiwara S; Ishii S; Hamasaki T; Okimoto N
    Arch Osteoporos; 2021 Jun; 16(1):106. PubMed ID: 34191131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials.
    Amiche MA; Albaum JM; Tadrous M; Pechlivanoglou P; Lévesque LE; Adachi JD; Cadarette SM
    Osteoporos Int; 2016 May; 27(5):1709-18. PubMed ID: 26694595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of vertebral fractures among patients with chronic obstructive pulmonary disease in Canada.
    Papaioannou A; Parkinson W; Ferko N; Probyn L; Ioannidis G; Jurriaans E; Cox G; Cook RJ; Kumbhare D; Adachi JD
    Osteoporos Int; 2003 Nov; 14(11):913-7. PubMed ID: 14551675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study.
    Abtahi S; Driessen JHM; Burden AM; Souverein PC; van den Bergh JP; van Staa TP; Boonen A; de Vries F
    Ann Rheum Dis; 2021 Apr; 80(4):423-431. PubMed ID: 33310727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-hip and non-vertebral fractures: the neglected fracture sites.
    Holloway KL; Henry MJ; Brennan-Olsen SL; Bucki-Smith G; Nicholson GC; Korn S; Sanders KM; Pasco JA; Kotowicz MA
    Osteoporos Int; 2016 Mar; 27(3):905-913. PubMed ID: 26438309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time trends for alendronate prescription practices in women with chronic obstructive pulmonary disease and women exposed to systemic glucocorticoids.
    Brask-Lindemann D; Eiken P; Eskildsen P; Abrahamsen B
    Osteoporos Int; 2013 Jun; 24(6):1891-7. PubMed ID: 23152095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy.
    Van Staa TP; Laan RF; Barton IP; Cohen S; Reid DM; Cooper C
    Arthritis Rheum; 2003 Nov; 48(11):3224-9. PubMed ID: 14613287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled glucocorticoids are associated with vertebral fractures in COPD patients.
    Gonçalves PA; Dos Santos Neves R; Neto LV; Madeira M; Guimarães FS; Mendonça LMC; Lopes AJ; Farias MLF
    J Bone Miner Metab; 2018 Jul; 36(4):454-461. PubMed ID: 28766137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fracture risk with intermittent high-dose oral glucocorticoid therapy.
    De Vries F; Bracke M; Leufkens HG; Lammers JW; Cooper C; Van Staa TP
    Arthritis Rheum; 2007 Jan; 56(1):208-14. PubMed ID: 17195223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting fracture risk in patients with chronic obstructive pulmonary disease: a UK-based population-based cohort study.
    Akyea RK; McKeever TM; Gibson J; Scullion JE; Bolton CE
    BMJ Open; 2019 Apr; 9(4):e024951. PubMed ID: 30948576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose oral glucocorticoid therapy and risk of osteoporotic fractures in patients with rheumatoid arthritis: a cohort study using the Clinical Practice Research Datalink.
    Abtahi S; Driessen JHM; Burden AM; Souverein PC; van den Bergh JP; van Staa TP; Boonen A; de Vries F
    Rheumatology (Oxford); 2022 Apr; 61(4):1448-1458. PubMed ID: 34255815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic obstructive pulmonary disease and allied conditions is a strong independent risk factor for osteoporosis and pathologic fractures: a population-based cohort study.
    Chen SJ; Liao WC; Huang KH; Lin CL; Tsai WC; Kung PT; Chang KH; Kao CH
    QJM; 2015 Aug; 108(8):633-40. PubMed ID: 25614611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between statin use and osteoporotic fracture in patients with chronic obstructive pulmonary disease: a population-based, matched case-control study.
    Chen HY; Su PY; Lin TK; Jong GP
    Lipids Health Dis; 2020 Nov; 19(1):232. PubMed ID: 33143674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.